Diyun Xu

Direct cardio-protection of Dapagliflozin against obesity-related cardiomyopathy via NHE1/MAPK signaling

Ke Lin, Na Yang, Wu Luo et al. · Acta Pharmacologica Sinica · 2022 · 67 citations · Full text

Medicine, Cardiology, Pharmacology +11

Podocyte OTUD5 alleviates diabetic kidney disease through deubiquitinating TAK1 and reducing podocyte inflammation and injury

Ying‐Yong Zhao, Shijie Fan, Hong Zhu et al. · Nature Communications · 2024 · 43 citations · Full text

Medicine, Biochemistry, Molecular Biology +17

Dectin-1 deficiency alleviates diabetic cardiomyopathy by attenuating macrophage-mediated inflammatory response

Na Yang, Minxiu Wang, Ke Lin et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2023 · 24 citations

Life Sciences, Immunology, Physiology +16

Sclareol attenuates angiotensin <scp>II</scp>‐induced cardiac remodeling and inflammation via inhibiting <scp>MAPK</scp> signaling

Na Yang, Chunpeng Zou, Wu Luo et al. · Phytotherapy Research · 2022 · 21 citations

Medicine, Cardiology, Pharmacology +17

Inhibition of TAK1/TAB2 complex formation by costunolide attenuates obesity cardiomyopathy via the NF-κB signaling pathway

Bozhi Ye, Xudong Chen, Yanghao Chen et al. · Phytomedicine · 2022 · 19 citations

Life Sciences, Molecular Biology, Pharmacology +10